Physician profile
Sara A Silver
NPI 1780824714
$1,008.30
in general payments reported to CMS, 2019-2025
17 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $31.91 · 2022: $73.78 · 2023: $149 · 2024: $120 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647 · Education: $23.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.35 |
| Education | $23.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.88 | 2019-2025 | |
| Azurity Pharmaceuticals, INC. | $114.36 | 2022-2024 | Triptodur, Triptodur |
| Novo Nordisk INC | $108.10 | 2019-2025 | Sogroya, Wegovy |
| Sanofi-Aventis U.S. LLC | $74.05 | 2025 | |
| Sequel Med Tech, LLC | $71.83 | 2025 | Twiist |
| Neurocrine Biosciences, INC. | $71.21 | 2024-2025 | |
| Tandem Diabetes Care, INC. | $52.30 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $49.39 | 2019 | |
| Kyowa Kirin, INC. | $28.11 | 2023-2025 | Crysvita |
| Medtronic Minimed, INC. | $23.91 | 2019 | |
| Dexcom, INC. | $20.10 | 2019 | |
| Eton Pharmaceuticals, INC. | $19.03 | 2023 | Alkindi |
| Ascendis Pharma Endocrinology INC | $18.48 | 2024 | |
| Arbor Pharmaceuticals, INC. | $17.75 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.34 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.